Guardant Health Inc. (GH)

Trade GH now with
2/2/2023 6:13:54 AM U.S. Court Issues Favorable Recommendation Regarding Guardant Health's Motion To Dismiss Lawsuit Brought By Illumina
1/30/2023 7:08:46 AM Guardant Health: FDA Approves Guardant360 CDx Liquid Biopsy Test
1/9/2023 8:08:45 AM Guardant Health Reports Q4 Preliminary Revenue Of $124 Mln To $127 Mln
12/16/2022 10:34:47 AM Guardant Health Falls 30%
8/31/2022 8:12:21 AM Guardant Health Expands Collaboration With Merck KGaA On Oncology Therapeutics
7/7/2022 8:08:28 AM Guardant Health Appoints Steve Krognes To Board
7/6/2022 6:19:54 AM Guardant Health Announces Strategic Partnership To Offer Comprehensive Genomic Profiling Tests In China
6/22/2021 8:13:03 AM Guardant Health Adds New Products To Portfolio To Help Improve Management Of Patients With Metastatic Cancers
6/8/2021 8:09:32 AM Guardant Health Appoints Chris Freeman As Chief Commercial Officer For Its Oncology Business
5/28/2021 1:54:12 AM Guardant Health Says Files Lawsuit Against Natera For Misleading Oncologists
5/3/2021 8:12:30 AM Guardant Health Appoints Craig Eagle As Chief Medical Officer
4/27/2021 8:11:41 AM Guardant Health Announces Collaboration With Daiichi Sankyo To Develop Guardant360 CDx
3/30/2021 8:12:46 AM Guardant Health Receives ADLT Status From CMS For FDA-Approved Guardant360 CDx Test
1/27/2021 8:08:00 AM Guardant Health: Study Shows Guardant360 Liquid Biopsy Outperforms Tissue Biopsy For Genomic Profiling In Advanced NSCLC
1/18/2021 3:14:57 AM Guardant Health And Vall D'Hebron Institute Of Oncology Announce Partnership
3/13/2019 9:11:06 AM William Blair Reiterates Guardant Health Inc. (GH) At Outperform